Literature DB >> 20643590

Comparative pharmacokinetics of baicalin and wogonoside by liquid chromatography-mass spectrometry after oral administration of Xiaochaihu Tang and Radix scutellariae extract to rats.

Zhenyu Zhu1, Liang Zhao, Xiaofan Liu, Jun Chen, Hai Zhang, Guoqing Zhang, Yifeng Chai.   

Abstract

The aim of this study was to compare the pharmacokinetics of baicalin and wogonoside in rats following oral administration of Xiaochaihu Tang (Minor Radix Bupleuri Decoction) and Radix scutellariae extract. Thus, a specific LC-MS method was developed and validated for the determination of these flavonoids in the plasma of rats after oral administration Xiaochaihu Tang and Radix scutellariae extract. Chromatographic separation was performed on a Zorbax SB C(18) column (150mmx4.6mm, i.d.: 5microm) with 0.1% formic acid in water and acetonitrile by linear gradient elution. Baicalin, wogonoside and carbamazepine (internal standard, I.S.) were detected in select-ion-monitoring (SIM) mode with a positive electrospray ionization (ESI) interface. The following ions: m/z 447 for baicalin, m/z 461 for wogonoside and m/z 237 for the I.S. were used for quantitative determination. The calibration curves were linear over the concentration ranges from 0.1231 to 6.156microg mL(-1) for baicalin and 0.08832 to 4.416microg mL(-1) for wogonoside. The lower limit of detection (LLOD) based on a signal-to-noise ratio of 2 was 0.06155microg mL(-1) for baicalin and 0.04416microg mL(-1) for wogonoside. Intra-day and inter-day precisions (RSD%) were within 10% and accuracy (RE%) ranged from -6.4 to 4.4%. The extraction recovery at three QC concentrations ranged from 74.7 to 86.0% for baicalin and from 71.3 to 83.7% for wogonoside. The plasma concentrations of baicalin and wogonoside in rats at designated time periods after oral administration were successfully determined using the validated method, pharmacokinetic parameters were estimated by a non-compartment model. Following oral administration of Xiaochaihu Tang and Radix scutellariae extract, the t(1/2) of baicalin was 3.60+/-0.90 and 5.64+/-1.67, the C(max1) was 1.64+/-0.99 and 5.66+/-2.02, the t(max1) was 0.13+/-0.05 and 0.20+/-0.07, the C(max2) was 2.43+/-0.46 and 3.18+/-1.66, and the t(max2) were 6.40+/-1.67 and 5.66+/-2.02, respectively. Following oral administration of Xiaochaihu Tang and Radix scutellariae extract, the t(1/2) of wogonoside was 4.97+/-1.68 and 7.71+/-1.55, the C(max1) was 1.39+/-0.83 and 1.45+/-0.37, the t(max1) was 0.21+/-0.20 and 0.17+/-0.01, the C(max2) was 1.90+/-0.55 and 1.42+/-0.70, and the t(max2) was 5.60+/-1.67 and 5.20+/-1.79, respectively. A significant difference (p<0.05) was observed for t(1/2), and the elimination of baicalin and wogonoside in Xiaochaihu Tang was increased. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20643590     DOI: 10.1016/j.jchromb.2010.06.021

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  12 in total

1.  Simultaneous determinations of 17 marker compounds in Xiao-Chai-Hu-Tang by LC-MS/MS: Application to its pharmacokinetic studies in mice.

Authors:  Rongjin Sun; Min Zeng; Ting Du; Li Li; Guangyi Yang; Ming Hu; Song Gao
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2015-09-11       Impact factor: 3.205

2.  Comparative pharmacokinetics of baicalin, wogonoside, baicalein and wogonin in plasma after oral administration of pure baicalin, radix scutellariae and scutellariae-paeoniae couple extracts in normal and ulcerative colitis rats.

Authors:  Zhen-Qiu Zhang; Wei Liua; Li Zhuang; Jing Wang; Shuai Zhang
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

Review 3.  Applications of HPLC/MS in the analysis of traditional Chinese medicines.

Authors:  Miao Li; Xiao-Fang Hou; Jie Zhang; Si-Cen Wang; Qiang Fu; Lang-Chong He
Journal:  J Pharm Anal       Date:  2012-01-30

4.  Anti-Helicobacter pylori and Anti-Inflammatory Effects and Constituent Analysis of Modified Xiaochaihutang for the Treatment of Chronic Gastritis and Gastric Ulcer.

Authors:  Xin Chen; Lijuan Hu; Huanhuan Wu; Wei Liu; Shuhe Chen; Aijun Zhou; Yanwen Liu
Journal:  Evid Based Complement Alternat Med       Date:  2018-02-26       Impact factor: 2.629

5.  A rapid and sensitive liquid chromatography-tandem mass spectrometric method for the determination of hederasaponin B in rat plasma: Application to a pharmacokinetic study.

Authors:  Jiaxin Liu; Xueyan Yang; Lin Li; Qili Zhang; Zhaoyan Zhang; Xin Zhang; Yunli Zhao; Miao Yu; Zhiguo Yu
Journal:  Asian J Pharm Sci       Date:  2016-09-22       Impact factor: 6.598

Review 6.  Antiviral Properties of Baicalin: a Concise Review.

Authors:  Kunwei Li; Yiyu Liang; Ao Cheng; Qi Wang; Ying Li; Haocheng Wei; Changzheng Zhou; Xinhuan Wan
Journal:  Rev Bras Farmacogn       Date:  2021-10-06       Impact factor: 2.010

7.  Network Pharmacological Analysis and Experimental Study of the Antipharyngitis Mechanism of the Chaiqin Qingning Capsule.

Authors:  Can Wang; Hongjin Gao; Lianzhan Huang; Zhen Wang; Xuansheng Ding
Journal:  Biomed Res Int       Date:  2022-04-28       Impact factor: 3.246

8.  The development and validation of an HPLC-MS/MS method for the determination of eriocitrin in rat plasma and its application to a pharmacokinetic study.

Authors:  Luya Li; Rui Feng; Xue Feng; Yuting Chen; Xin Liu; Wenjing Sun; Lantong Zhang
Journal:  RSC Adv       Date:  2020-03-12       Impact factor: 4.036

9.  HPLC-MS/MS analysis of a traditional Chinese medical formulation of Bu-Yang-Huan-Wu-Tang and its pharmacokinetics after oral administration to rats.

Authors:  Lee-Hsin Shaw; Lie-Chwen Lin; Tung-Hu Tsai
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

10.  Putative multiple reaction monitoring strategy for the comparative pharmacokinetics of postoral administration Renshen-Yuanzhi compatibility through liquid chromatography-tandem mass spectrometry.

Authors:  Yufei Sun; Guifang Feng; Yan Zheng; Shu Liu; Yan Zhang; Zifeng Pi; Fengrui Song; Zhiqiang Liu
Journal:  J Ginseng Res       Date:  2018-10-09       Impact factor: 6.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.